SILVER, LH. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group. Am J Ophthalmol. 1998, 126, 400-408
SILVER, LH. Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution. Results from two multicenter comfort studies. Surv Ophthalmol. 2000, 44, 141-145
BECKER, B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, Diamox. Am J Opthalmol. 1954, 37, 13-15
JEAN-ERIC, M. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001, 132, 235-243
INGRAM, CJ. Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes. Am J Ophthalmol. 1999, 128, 292-296